KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Equity Ratio (2016 - 2025)

Evolent Health has reported Equity Ratio over the past 12 years, most recently at 0.22 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.22 for Q4 2025, down 44.45% from a year ago — trailing twelve months through Dec 2025 was 0.22 (down 44.45% YoY), and the annual figure for FY2025 was 0.22, down 44.45%.
  • Equity Ratio for Q4 2025 was 0.22 at Evolent Health, down from 0.34 in the prior quarter.
  • Over the last five years, Equity Ratio for EVH hit a ceiling of 0.49 in Q4 2021 and a floor of 0.22 in Q4 2025.
  • Median Equity Ratio over the past 5 years was 0.42 (2024), compared with a mean of 0.42.
  • Biggest five-year swings in Equity Ratio: crashed 45.47% in 2021 and later grew 3.09% in 2024.
  • Evolent Health's Equity Ratio stood at 0.49 in 2021, then fell by 3.22% to 0.47 in 2022, then decreased by 15.77% to 0.4 in 2023, then dropped by 1.21% to 0.39 in 2024, then tumbled by 44.45% to 0.22 in 2025.
  • The last three reported values for Equity Ratio were 0.22 (Q4 2025), 0.34 (Q3 2025), and 0.36 (Q2 2025) per Business Quant data.